(Q43852073)

Revision as of 10:19, 30 October 2023 by KrBot (talk | contribs) (‎Changed English label: Prognostic significance of residual tumor in patients with epithelial ovarian carcinoma stage IV in a 20 year perspective)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

English

Prognostic significance of residual tumor in patients with epithelial ovarian carcinoma stage IV in a 20 year perspective

scientific article published on 9 January 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Prognostic significance of residual tumor in patients with epithelial ovarian carcinoma stage IV in a 20 year perspective. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

ovarian carcinoma

1 reference

based on heuristic

inferred from title

Claes Göran Tropé

5

object named as

Claes G Tropé

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

Mari B Elstrand

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Berit Sandstad

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Halldis Oksefjell

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Ben Davidson

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

9 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Acta Obstetricia et Gynecologica Scandinavica

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

91

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

308-317

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2011.01316.X

21 January 2018

Prognostic significance of residual disease in patients with stage IV epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2011.01316.X

21 January 2018

Stage IV ovarian cancer: impact of surgical debulking

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2011.01316.X

21 January 2018

Effect of surgical debulking on survival in stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2011.01316.X

21 January 2018

Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2011.01316.X

21 January 2018

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2011.01316.X

21 January 2018

Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2011.01316.X

21 January 2018

Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease: an exploratory analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2011.01316.X

21 January 2018

Does neoadjuvant chemotherapy increase optimal cytoreduction rate in advanced ovarian cancer? Meta-analysis of 21 studies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2011.01316.X

21 January 2018

Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2011.01316.X

21 January 2018

The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2011.01316.X

21 January 2018

Delaying the primary surgical effort for advanced ovarian cancer: a systematic review of neoadjuvant chemotherapy and interval cytoreduction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2011.01316.X

21 January 2018

Treatment goals in ovarian cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2011.01316.X

21 January 2018

Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2011.01316.X

21 January 2018

CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2011.01316.X

21 January 2018

The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2011.01316.X

21 January 2018

Diagnostic open laparoscopy in the management of advanced ovarian cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0412.2011.01316.X

21 January 2018

Identifiers

10.1111/J.1600-0412.2011.01316.X

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43852073&oldid=2000607100"